肢端肥大症治疗对心血管并发症的影响。 - Suppr

Suppr

超能文献

Impact of acromegaly treatment on cardiovascular complications.

作者信息

Ioachimescu Adriana G

机构信息

Emory University School of Medicine, 1365 B Clifton Road, NE, B6209, Atlanta, GA , 30322 , USA.

出版信息

Endocrine. 2017 Mar;55(3):659-661. doi: 10.1007/s12020-016-1218-9. Epub 2017 Feb 3.

DOI:10.1007/s12020-016-1218-9

PMID:28155173

Abstract

摘要

相似文献

Impact of acromegaly treatment on cardiovascular complications.肢端肥大症治疗对心血管并发症的影响。

Endocrine. 2017 Mar;55(3):659-661. doi: 10.1007/s12020-016-1218-9. Epub 2017 Feb 3.

Cardiovascular Disease and Sleep-Disordered Breathing in Acromegaly.肢端肥大症中的心血管疾病与睡眠呼吸障碍

Neuroendocrinology. 2016;103(1):75-85. doi: 10.1159/000438903. Epub 2015 Jul 28.

Cardiovascular Disease in Acromegaly.肢端肥大症中的心血管疾病

Methodist Debakey Cardiovasc J. 2017 Apr-Jun;13(2):64-67. doi: 10.14797/mdcj-13-2-64.

Severe systemic complications of acromegaly.肢端肥大症的严重全身并发症。

J Endocrinol Invest. 2005;28(5 Suppl):65-77.

[Cardiovascular manifestatons of acromegaly].[肢端肥大症的心血管表现]

Presse Med (1893). 1962 Mar 3;70:521-3.

[Heart disease in acromegaly. Study of 27 patients].[肢端肥大症中的心脏病。27例患者的研究]

Med Clin (Barc). 1996 Sep 21;107(9):326-30.

Complications of acromegaly: cardiovascular, respiratory and metabolic comorbidities.肢端肥大症的并发症：心血管、呼吸及代谢共病

Pituitary. 2017 Feb;20(1):46-62. doi: 10.1007/s11102-017-0797-7.

Cardiovascular comorbidities in acromegaly: an update on their diagnosis and management.肢端肥大症中的心血管合并症：诊断与管理的最新进展

Endocrine. 2017 Feb;55(2):346-359. doi: 10.1007/s12020-016-1191-3. Epub 2017 Jan 2.

5 Long-term acromegaly and associated cardiovascular complications: a case-based review.肢端肥大症的长期病程及相关心血管并发症：基于病例的综述

Best Pract Res Clin Endocrinol Metab. 2009 Dec;23 Suppl 1:S31-8. doi: 10.1016/S1521-690X(09)70006-5.

[Case of cardiac affection in acromegaly].[肢端肥大症中心脏病变病例]

Klin Med (Mosk). 1950 Oct;18(10):71-2.

引用本文的文献

Effects of somatostatin analog treatment on cardiovascular parameters in patients with acromegaly: A systematic review.生长抑素类似物治疗对肢端肥大症患者心血管参数的影响：一项系统评价。

J Res Med Sci. 2019 Apr 26;24:29. doi: 10.4103/jrms.JRMS_955_18. eCollection 2019.

Bringing Cardiovascular Comorbidities in Acromegaly to an Update. How Should We Diagnose and Manage Them?肢端肥大症中心血管合并症的最新进展。我们应如何诊断和管理这些合并症？

Front Endocrinol (Lausanne). 2019 Mar 7;10:120. doi: 10.3389/fendo.2019.00120. eCollection 2019.

本文引用的文献

Disease activity and lifestyle influence comorbidities and cardiovascular events in patients with acromegaly.疾病活动和生活方式会影响肢端肥大症患者的合并症和心血管事件。

Eur J Endocrinol. 2016 Nov;175(5):443-53. doi: 10.1530/EJE-16-0562. Epub 2016 Aug 15.

Effects of long-term combined treatment with somatostatin analogues and pegvisomant on cardiac structure and performance in acromegaly.生长抑素类似物与培维索孟长期联合治疗对肢端肥大症患者心脏结构和功能的影响。

Endocrine. 2017 Mar;55(3):872-884. doi: 10.1007/s12020-016-0995-5. Epub 2016 Jun 13.

Acromegaly incidence, prevalence, complications and long-term prognosis: a nationwide cohort study.肢端肥大症的发病率、患病率、并发症及长期预后：一项全国性队列研究

Eur J Endocrinol. 2016 Sep;175(3):181-90. doi: 10.1530/EJE-16-0117. Epub 2016 Jun 8.

Current and Emerging Aspects of Diabetes Mellitus in Acromegaly.肢端肥大症中糖尿病的现状和新进展。

Trends Endocrinol Metab. 2016 Jul;27(7):470-483. doi: 10.1016/j.tem.2016.04.014. Epub 2016 May 24.

Mortality in acromegaly: a 20-year follow-up study.肢端肥大症的死亡率：一项20年的随访研究。

Endocr Relat Cancer. 2016 Jun;23(6):469-80. doi: 10.1530/ERC-16-0106. Epub 2016 May 16.

Cardiovascular System Changes and Related Risk Factors in Acromegaly Patients: A Case-Control Study.肢端肥大症患者的心血管系统变化及相关危险因素：一项病例对照研究。

Int J Endocrinol. 2015;2015:573643. doi: 10.1155/2015/573643. Epub 2015 Oct 27.

Low Frequency of Cardiomyopathy Using Cardiac Magnetic Resonance Imaging in an Acromegaly Contemporary Cohort.肢端肥大症当代队列中心脏磁共振成像显示心肌病发病率低。

J Clin Endocrinol Metab. 2015 Dec;100(12):4447-55. doi: 10.1210/jc.2015-2675. Epub 2015 Oct 2.

Long-term effects of pegvisomant on comorbidities in patients with acromegaly: a retrospective single-center study.培维索孟对肢端肥大症患者合并症的长期影响：一项回顾性单中心研究。

Eur J Endocrinol. 2015 Nov;173(5):693-702. doi: 10.1530/EJE-15-0500.

Successful mortality reduction and control of comorbidities in patients with acromegaly followed at a highly specialized multidisciplinary clinic.在高度专业化的多学科诊所接受治疗的肢端肥大症患者，其死亡率降低和共病控制取得成功。

J Clin Endocrinol Metab. 2014 Dec;99(12):4438-46. doi: 10.1210/jc.2014-2670.

Comparison of the effects of primary somatostatin analogue therapy and pituitary adenomectomy on survival in patients with acromegaly: a retrospective cohort study.肢端肥大症患者中，生长抑素类似物治疗与垂体腺瘤切除术对生存影响的比较：一项回顾性队列研究。

Eur J Endocrinol. 2013 Aug 28;169(3):367-76. doi: 10.1530/EJE-13-0166. Print 2013 Sep.

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验